Literature DB >> 4939890

The continued use of amantadine hydrochloride in parkinsonism.

D B Appleton, M J Eadie, J M Sutherland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4939890     DOI： 10.5694/j.1326-5377.1971.tb92500.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  3 in total

1.  Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa.

Authors:  L R Zeldowicz; J Hubermann
Journal:  Can Med Assoc J       Date:  1973-10-06       Impact factor: 8.262

2.  Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.

Authors:  J D Parkes; R C Baxter; C D Marsden; J E Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

Review 3.  Amantadine in Parkinson's disease.

Authors:  N Crosby; K H Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.